Immunochina Raises $20.4 Million USD in Series C Financing

Life Science

I-Mab Approved to Start US Trials of Immunotherapy for Solid Tumors

Life Science

Cannabis stocks break their three-week winning streak, despite positive pot news in U.S.

Cannabis, Life Science

Samsung Bioepis’ First Cancer Biosimilar Approved by the FDA

Life Science

AOTI Enters Into Multi-Million USD Strategic Relationship for Chinese Market

Life Science

iKang Healthcare Closes $1.4 Billion Privatization, Led by Alibaba

Life Science

CVS, Walmart reach an agreement on a pharmacy contract after impasse

Life Science

Yield Growth Expands Innovative Topicals Line into Oregon inShare

Cannabis, Life Science

Canadian stocks post their best start to the year since 1980

Cannabis, Life Science

J&J and Apple Team up for AFib Program With Apple Watch

Life Science, Technology

Johnson & Johnson Completes Acquisition of Ci:z Holdings Co., Ltd.

Life Science

Pharmerit Expands Market Access Support in Asia

Life Science

Cellular Biomedicine Group’s AlloJoin® Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials

Life Science

MabPlex, a China Biologic CDMO, Closes $59 million Series A

Life Science

Boehringer Ingelheim Expands Shanghai Biologics CDMO Facility

Life Science